Latest Commercial Partnerships News

4DMedical has submitted its CT:VQ lung imaging technology for FDA clearance, aiming to disrupt the $1 billion US nuclear lung scan market with a non-nuclear, lower-cost alternative. Clinical studies show CT:VQ matches or exceeds existing nuclear imaging in accuracy and patient experience.

Jade Gas Holdings has completed Mongolia’s inaugural horizontal coal bed methane wells at the Red Lake field, setting the stage for initial gas production by early June 2025. The company is advancing commercial partnerships to leverage this milestone for cleaner energy solutions in the South Gobi region.

Despite a tough 2024 NRL season for the men's team, Brisbane Broncos delivered record memberships, increased attendance, and a solid financial performance with a $5.7 million profit.

Urbanise.com Limited has entered a strategic partnership and equity investment agreement with National Australia Bank to launch integrated payment services for strata customers in early 2026.

OM Holdings has agreed to sell its 26% interest in Ntsimbintle Mining to Exxaro Resources for US$101.4 million, marking a strategic shift to refocus capital on core operations while maintaining a commercial partnership.

Bio-Gene Technology Limited has launched a Share Purchase Plan allowing Australian shareholders to invest up to $15,000 at 2.3 cents per share, matching a recent $2.1 million placement. The offer includes free-attaching options, subject to shareholder approval, to support key product development milestones.

Victor Group Holdings has established Victor Nexus Pty Ltd to deepen its fintech footprint in Australia and forged a strategic partnership with Shebah, aiming to empower women through innovative financial solutions.

MTM Critical Metals has clarified that recent spikes in its share price and trading volume are linked to an external US technology report, not undisclosed company information. The company reaffirms ongoing progress in its Flash Joule Heating technology and supply agreements.

BrainChip Holdings Ltd’s 2025 AGM reveals a strengthened product roadmap, breakthrough Edge AI technology advances, and a surge in commercial partnerships, positioning the company for accelerated growth.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Memphasys Limited has completed a pivotal Phase III trial confirming its Felix™ System as best-in-class for sperm separation, while advancing regulatory and commercial efforts in China and Brazil supported by fresh capital.

Clime Investment Management has been appointed lead manager for a significant US public offer fund by Sphinx Investments, with initial allocations of $183 million AUD pending SEC approval. The move marks a strategic expansion into the US market, complemented by new wholesale offerings and a partnership with a Dallas-based equities manager.